TrianglePUBLICATIONS · 2295904
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1990 Jan
- First author
- Howell SB
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Howell SB
- type
- Author
- name
- Kirmani S
- type
- Author
- name
- Lucas WE
- type
- Author
- name
- Zimm S
- type
- Author
- name
- Goel R
- type
- Author
- name
- Kim S
- type
- Author
- name
- Horton MC
- type
- Author
- name
- McVey L
- type
- Author
- name
- Morris J
- type
- Author
- name
- Weiss RJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Howell SB
- type
- Author
- name
- Kirmani S
- type
- Author
- name
- Lucas WE
- type
- Author
- name
- Zimm S
- type
- Author
- name
- Goel R
- type
- Author
- name
- Kim S
- type
- Author
- name
- Horton MC
- type
- Author
- name
- McVey L
- type
- Author
- name
- Morris J
- type
- Author
- name
- Weiss RJ
- type
- Author
- bibliography ids
- nci-bib-c83d535c30f4b6715952d4ba
- book metadata
- content sha256
- fa01eb6f087a1bd3855d598df59e13e908ba700febcf22a2d5005d695094a8a4
- document type
- citation
- dois
- 10.1200/JCO.1990.8.1.137
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:2295904
- immutable id
- pubmed:2295904@fa01eb6f087a1bd3855d598df59e13e908ba700febcf22a2d5005d695094a8a4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 137-45
- volume
- 8
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 2295904
- provenance
- batch id
- a86a47b66cb510ab0246
- provider
- NCBI PubMed ESummary
- record sha256
- d0617560ee2a2cdc652821446572c78537744d37774c738f470c12e358da0cf8
- response sha256
- 62fa1bbcbdc25a5665b7097f6b22fc4289465701bcd0c8efaebd75831ecd761d
- retrieved at
- 2026-09-09T23:45:08.918507+00:00
- publication date
- display
- 1990 Jan
- precision
- month
- year
- 1990
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/2295904/
- title
- A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
Preserved source evidence · Not medical advice